Details

Primerjava mikrobiote v blatu otrok s kronično vnetno črevesno boleznijo in funkcionalnimi motnjami prebavil : magistrsko delo
ID Magnay, Mojca (Author), ID Orel, Rok (Mentor) More about this mentor... This link opens in a new window, ID Bogovič Matijašić, Bojana (Comentor), ID Fidler Mis, Nataša (Reviewer)

.pdfPDF - Presentation file, Download (1,11 MB)
MD5: A7D92758B85968B341CEAB1DBE26859D

Language:Slovenian
Keywords:črevesje, črevesne bolezni, kronične vnetne črevesne bolezni, ulcerozni kolitis, Crohnova bolezen, prebavila, motnje delovanja, črevesna mikrobiota, blato, otroci
Work type:Master's thesis/paper
Typology:2.09 - Master's Thesis
Organization:BF - Biotechnical Faculty
Place of publishing:Ljubljana
Publisher:[M. Magnay]
Year:2016
Number of pages:XIV, 59 f., [7] f. pril.
PID:20.500.12556/RUL-118726 This link opens in a new window
UDC:616.34-053.2/.5
COBISS.SI-ID:4739704 This link opens in a new window
Publication date in RUL:31.08.2020
Views:1569
Downloads:134
Metadata:XML DC-XML DC-RDF
:
MAGNAY, Mojca, 2016, Primerjava mikrobiote v blatu otrok s kronično vnetno črevesno boleznijo in funkcionalnimi motnjami prebavil : magistrsko delo [online]. Master’s thesis. Ljubljana : M. Magnay. [Accessed 13 April 2025]. Retrieved from: https://repozitorij.uni-lj.si/IzpisGradiva.php?lang=eng&id=118726
Copy citation
Share:Bookmark and Share

Secondary language

Language:English
Title:Comparison of fecal microbiota of children with chronic inflammatory bowel disease and functional bowel disorders : M. Sc. Thesis
Keywords:bowel, bowel disease, chronic inflammatory bowel disease, ulcerative colitis, Crohn disease, gastrointestinal tract, functional disorders, fecal microbiota, feces, children

Similar documents

Similar works from RUL:
  1. Infliximab through as a biomarker for inflammatory bowel disease
  2. Development of genetically modified lactic acid bacteria for the treatment of inflammatory bowel disease
  3. ǂThe ǂanalysis of side effects of infliximab therapy on skin of patients suffering from inflammatory bowel disease
  4. Determination of anti-TNF biologic drugs and anti-drug antibodies in inflammatory bowel disease
  5. Infliximab serum concentration as a potential predictor of its efficacy and safety in inflammatory bowel disease treatment
Similar works from other Slovenian collections:
  1. Nursing care of child with chronic inflammatory bowel (Crohn's disease)
  2. Genome-wide association analysis of Slovenian inflammatory bowel disease patients
  3. ǂThe ǂimportance of proper nutrition in inflammatory bowel disease
  4. Use of biological agents at University clinical center Maribor
  5. MOLECULAR CHANGES AND PHARMACOGENOMIC BIOMARKERS FOR CROHN DISEASE TREATMENT USING MONOCLONAL ANTIBODIES AGAINST TNFα

Back